Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention

Author:

Raposeiras-Roubín Sergio1,Abu-Assi Emad1,Caneiro Queija Berenice1,Cobas Paz Rafael1,D’Ascenzo Fabrizio2,Henriques Jose Paulo Simao3,Saucedo Jorge4,González-Juanatey José5,Wilton Stephen B6,Kikkert Wouter J3,Nuñez-Gil Iván7,Ariza-Sole Albert8,Song Xiantao9,Alexopoulos Dimitrios10,Liebetrau Christoph11,Kawaji Tetsuma12,Moretti Claudio2,Huczek Zenon13,Nie Shao-Ping14,Fujii Toshiharu15,Correia Luis16,Kawashiri Masa-aki17,Cespón Fernández María1,Muñoz-Pousa Isabel1,López Rodríguez Elena1,Castiñeira-Busto María1,Barreiro Pardal Cristina1,García-Acuña José María5,Southern Danielle6,Terol Belén7,Garay Alberto8,Zhang Dongfeng9,Chen Yalei9,Xanthopoulou Ioanna10,Osman Neriman11,Möllmann Helge11,Shiomi Hiroki12,Gaita Fiorenzo2,Kowara Michal13,Filipiak Krzysztof13,Wang Xiao14,Yan Yan14,Fan Jing-Yao14,Ikari Yuji15,Nakahayshi Takuya17,Sakata Kenji17,Yamagishi Masakazu17,Kedev Sasko18,Íñiguez-Romo Andrés1

Affiliation:

1. Alvaro Cunqueiro Hospital, Vigo, Spain

2. San Giovanni Battista Molinette Hospital, Turin, Italy

3. University of Amsterdam, Academic Medical Center, the Netherlands

4. NorthShore University Hospital, Chicago, USA

5. Univesity Clínical Hospital, Santiago de Compostela, Spain

6. Libin Cardiovascular Institute of Alberta, Calgary, Canada

7. San Carlos Hospital, Madrid, Spain

8. Bellvitge Hospital, Barcelona, Spain

9. Anzhen Hospital, Beijing, China

10. University Patras Hospital, Patras, Greece

11. Kerckhoff Heart and Thorax Center, Frankfurt, Germany

12. University Graduate School of Medicine, Kyoto, Japan

13. University Clinical Hospital, Warsaw, Poland

14. Beijing Anzhen Hospital, Capital Medical University, Beijing, China

15. Tokai University School of Medicine, Tokyo, Japan

16. Hospital Sao Rafael, Salvador, Brazil

17. University Graduate School of Medicine, Kanazawa, Japan

18. University Clinic of Cardiology, Skopje, Republic of Macedonia

Abstract

Background: The rate of intracranial haemorrhage after an acute coronary syndrome has been studied in detail in the era of thrombolysis; however, in the contemporary era of percutaneous coronary intervention, most of the data have been derived from clinical trials. With this background, we aim to analyse the incidence, timing, predictors and prognostic impact of post-discharge intracranial haemorrhage in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Methods: We analysed data from the BleeMACS registry (patients discharged for acute coronary syndrome and undergoing percutaneous coronary intervention from Europe, Asia and America, 2003–2014). Analyses were conducted using a competing risk framework. Uni and multivariate predictors of intracranial haemorrhage were assessed using the Fine–Gray proportional hazards regression analysis. The endpoint was 1-year post-discharge intracranial haemorrhage. Results: Of 11,136 patients, 30 presented with intracranial haemorrhage during the first year (0.27%). The median time to intracranial haemorrhage was 150 days (interquartile range 55.7–319.5). The fatality rate of intracranial haemorrhage was very high (30%). After multivariate analysis, only age (subhazard ratio 1.05, 95% confidence interval 1.01–1.07) and prior stroke/transient ischaemic attack (hazard ratio 3.29, 95% confidence interval 1.36–8.00) were independently associated with a higher risk of intracranial haemorrhage. Hypertension showed a trend to associate with higher intracranial haemorrhage rate. The combination of older age (⩾75 years), prior stroke/transient ischaemic attack, and/or hypertension allowed us to identify most of the patients with intracranial haemorrhage (86.7%). The annual rate of intracranial haemorrhage was 0.1% in patients with no risk factors, 0.2% in those with one factor, 0.6% in those with two factors and 1.3% in those with three factors. Conclusion: The incidence of intracranial haemorrhage in the first year after an acute coronary syndrome treated with percutaneous coronary intervention is low. Advanced age, previous stroke/transient ischaemic attack, and hypertension are the main predictors of increased intracranial haemorrhage risk.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,General Medicine

Reference22 articles.

1. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

2. TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

3. PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

4. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence;Palmerini;Eur Heart J,2016

5. Focused Update Writing Group. 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3